The discovery that finasteride, an FDA-approved drug, can effectively reverse tumor-induced M2 polarization through upregulation of ZBTB20 represents a major advancement in repurposing existing therapeutics for cancer immunotherapy. The gene discussed is ZBTB20; the disease is neoplasm.